Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers

被引：0
|
作者：
Rhodin, Kristen E. [1 ]
Liu, Annie [1 ]
Bartholomew, Alex [1 ]
Kramer, Ryan [2 ]
Parameswaran, Anika [1 ]
Uronis, Hope [3 ,4 ]
Strickler, John [3 ,4 ]
Hsu, David [3 ,4 ]
Morse, Michael A. [3 ,4 ]
Shah, Kevin N. N. [1 ]
Herbert, Garth [1 ]
Zani, Sabino [1 ,4 ]
Nussbaum, Daniel P. [1 ,4 ]
Allen, Peter J. [1 ,4 ]
Lidsky, Michael E. [1 ,4 ]
机构：
[1] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27707 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Duke Univ, Dept Med, Div Med Oncol, Med Ctr, Durham, NC USA
[4] Duke Canc Inst, Durham, NC USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 8期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1245/s10434-023-13637-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4824 / 4825
页数：2
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for resected biliary tract cancers: A fluorouracil-based scheme beats out a gemcitabine-based scheme for the win
    Hu, Ya-Fei
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    HEPATOLOGY, 2024, 79 (05) : 965 - 969
  • [32] Timing of adjuvant chemotherapy and impact on survival for resected gastric cancer.
    Greenleaf, Erin
    Hollenbeak, Christopher S.
    Wong, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [33] SURVIVAL IMPACT OF ADJUVANT CHEMOTHERAPY FOR RESECTED EARLY STAGE RECTAL ADENOCARCINOMA
    Tay, R.
    Jamnagerwalla, M.
    Steel, M.
    Wong, H. L.
    McKendrick, J. J.
    Faragher, I.
    Kosmider, S.
    Hastie, I.
    Desai, J.
    Harold, M.
    Gibbs, P.
    Wong, R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 66 - 66
  • [34] Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma
    Tay, Rebecca Y.
    Jamnagerwalla, Murtaza
    Steel, Malcolm
    Wong, Hui-Li
    McKendrick, Joseph J.
    Faragher, Ian
    Kosmider, Suzanne
    Hastie, Ian
    Desai, Jayesh
    Tacey, Mark
    Gibbs, Peter
    Wong, Rachel
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : E45 - E54
  • [35] ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES
    Ramsden, K.
    Laskin, J.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S31 - S32
  • [36] Reevaluating Adjuvant Capecitabine for Resected Biliary Tract Cancer
    Benjamin, David J.
    Prasad, Vinay
    ONCOLOGIST, 2024, 29 (02): : 100 - 101
  • [37] Adjuvant therapy for resected biliary tract cancer: a review
    Doherty, Mark K.
    Knox, Jennifer J.
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (05)
  • [38] Outcome of Adjuvant Therapy in Biliary Tract Cancers
    McNamara, Mairead G.
    Walter, Thomas
    Horgan, Anne M.
    Amir, Eitan
    Cleary, Sean
    McKeever, Elizabeth L.
    Min, Trisha
    Wallace, Elaine
    Hedley, David
    Krzyzanowska, Monika
    Moore, Malcolm
    Gallinger, Steven
    Greig, Paul
    Serra, Stefano
    Dawson, Laura A.
    Knox, Jennifer J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 382 - 387
  • [39] A systematic review and network meta-analysis of adjuvant therapy for curatively resected biliary tract cancers
    Kish, M.
    Chan, K.
    Perry, K.
    Ko, Y. J.
    CURRENT ONCOLOGY, 2020, 27 (01) : E20 - E26
  • [40] Impact of molecular profiling on survival in patients with advanced biliary tract cancers
    Antoun, L.
    Deneche, I.
    Boileve, A.
    Tarabay, A.
    Rouleau, E.
    El Rawadi, E.
    Eid, R.
    Lacroix, L.
    Valery, M.
    Boige, V.
    Dartigues, P.
    Bani, M.
    Smolenschi, C.
    Scoazec, J.
    Ducreux, M.
    Hollebecque, A.
    Malka, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S163 - S163
12345